期刊文献+

重症肌无力cICAM-1及TNF-α水平的检测 被引量:4

Detection of cICAM-1 and TNF-α in Serum of Patients with Myasthenia Gravis
下载PDF
导出
摘要 目的 探讨神经免疫性疾病重症肌无力 ( MG)患者血清中循环细胞间黏附分子 -1 ( c ICAM-1 )及肿瘤坏死因子 -α( TNF-α)水平变化 ,并观察伴或不伴胸腺瘤 MG患者特异性 T细胞的免疫应答及细胞因子对 MG的影响。方法 采用 ELISA法对 1 5例 MG患者血清 c ICAM-1和 TNF-α水平进行检测 ,并以 1 5例健康献血员作为对照。比较伴或不伴胸腺瘤 MG患者上述因子的变化。结果  1 5例 MG患者血清 c ICAM-1水平显著高于对照组 ( P<0 .0 5 ) ,血清 TNF-α水平非常显著高于对照组 ( P<0 .0 1 )。MG伴胸腺瘤 MG患者 c ICAM-1及 TNF-α水平高于不伴胸腺瘤组 ,但无统计学意义 (均 P>0 .0 1 )。结论  MG患者血中高水平 TNF-α可直接破坏乙酰胆碱受体 ( ACh R)或直接促进 B细胞分化、生长 ,从而增加乙酰胆碱受体抗体 ( ACh RAb)的产生。 c ICAM-1可能在中枢神经系统炎症反应的调节中起重要作用。 Objective To explore the changes of circulating adhesion molecule-1(cICAM-1) and tumor necrosis factor-α(TNF-α)in serum of with myasthenia gravis (MG) of,as well as the changes of these factors in the patients with or without thymoma.Methods The levels of cICAM-1 and TNF-α were determined with ELISA assay in 15 MG patients with thymoma while 15 healthy donors was served as a normal control (NC).Results The levels of cICAM-1 and TNF-α were significantly higher than those of NC group (P<0.05, P<0.01,respectively).There is no significant difference between the levels of those factors in the patients with or without thymoma (P<0.05,P<0.01,respectively).Conclusions The high level of TNF-α may directly destroy AChR or promote the differentiation and growth of B cells resulting in an enhanced production of AChRAb.Increase of cICAM-1 may play an important regulating role in the inflammatory response of central nerve system.
出处 《中国神经免疫学和神经病学杂志》 CAS 2002年第2期79-81,共3页 Chinese Journal of Neuroimmunology and Neurology
关键词 重症肌无力 循环细胞间黏附分子-1 肿瘤坏死因子-Α myasthenia gravis circulating adhesion molecule-1 tumor necrosis factor-α
  • 相关文献

参考文献5

  • 1Jelinek DF,Lipaky PE.Enhancement of humman B cell proliferation and differentiation by tumor necrosis factor - and IL-1[].J Immunol.1987
  • 2Yotota S,Gepert TD,Lipsky PE.Enhacepmeht of antigen and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor -[].J Immunol.1988
  • 3Drachman DB.Myasthenia gravis[].The New England Journal of Medicine.1994
  • 4Matusevcius D,Navikas V,Palask W.Tumor necrosis factor - , lymphotoxin, IL-6, IL-10, IL-12 and perforin Mrna experession in mononuclear cells in response to AChR is augumented in myasthenia gravis[].J Neuroimmunol.1996
  • 5Tesar V,Jelinkova E,Jirsa M.Soluble adhesive molecules and cytokines in patients with myasthenia gravis treated with plasmaphereisis[].Casopis Lekaru Ceskych.1998

同被引文献17

  • 1管宇宙,崔丽英,李延峰.100例重症肌无力患者肿瘤坏死因子-α分泌活性的研究[J].中国神经免疫学和神经病学杂志,2004,11(4):187-190. 被引量:9
  • 2Yu-zhouGuan Li-yingCui Yan-fengLi Jun-baoZhang.TUMOR NECROSIS FACTOR-ALPHA POLYMORPHISM AND SECRETION IN MYASTHENIA GRAVIS[J].Chinese Medical Sciences Journal,2005,20(2):104-107. 被引量:10
  • 3刘银红,陈涓,刘芳,侯世芳,盛爱珍,刘明,秦绍森,郑剑晖.缺血性脑卒中急性期CT灌注成像与临床的相关性[J].中华神经科杂志,2005,38(7):418-420. 被引量:14
  • 4Paas-Rozner M,Dayan M,Paas Y,et al. Oral administration, of adual analog of two myasthenogenic T cell epitopes down-regulatesexperimental autoimmune myasthenia gravis in mice [ J]. Proc NatlAcad Sci USA, 2000 , 97(6) : 2168-2173.
  • 5Paas-Rozner M, Sela M, Mozes E. Tlie nature of the active sup-pression of responses associated with experimental autoimmune my-asthenia gravis by a dual altered peptide ligand administered bydifferent routes. [ J ]. Proc Natl Acad Sci USA,2001,98 (22 ):12642-12647.
  • 6Lennon VA, Lambert EH, Leiby KR, et al. Recombinant humanacetylcoline receptor a-subunit induces experimental autalimmunemyasthenia gravis[ J]. J Immunol, 1991,146(7):2245-2248.
  • 7Aruna BV,Ben-David H, Sela M, et al. A dual altered peptideligand down-regulates myasthenogenic T cell responses and rever-ses experimental autoimmune myasthenia gravis via up-regulation ofFas-FasL-mediated apoptosis [ J ]. Immunology,2006,118 (3 ):413-424.
  • 8Dayan M, Sthoeger Z, Neiman A, et al. Immunomodulation by adual altered peptide ligand of autoreactive responses to the acetyl-choline receptor of peripheral blood lymphocytes of patients withmyasthenia gravis[ J]. Hum Immunol, 2004, 65(6) : 571-577.
  • 9Struckmann K, Mertz K, Steu S, et al. pVHL co-ordinately regu-lates CXCR4/CXCL12 and MMP2/MMP9 expression in humanclear-cell renal cell carcinoma[ J]. I Pathol,2008 ,214(4) : 464-471.
  • 10Mahlknecht U, Schonbein C. Histone deacetylase inhibitor treat-ment downregulates VLA-4 adhesion in hematopoietic stem cellsand acute myeloid leukemia blast cells[ J]. Haematologica, 2008,93(3) : 443-446.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部